Dr. Jeffrey Millman is an Assistant Professor of Medicine and Biomedical Engineering at the Washington University in St. Louis School of Medicine. His research focuses on the generation of pancreatic insulin-producing β from human pluripotent stem cells for use in cellular replacement therapy and drug screening.